Home
Chemistry Department
Courses Taught
Research
Research Group
Publications
Positions Available
Research Funding
Chemistry Links
Contact Us
|
Dr Amitabh Jha, M.Sc., Ph.D. (Delhi)
Conference
Lectures and Posters
Conference
Lectures from my Research Group:
15. |
Jha A
A green methodology involving multi-component cascade
reactions. 3rd IUPAC Conference on Green Chemistry, August
15-18, 2010, Ottawa. |
14. |
Jha A
Development of novel selective estrogen receptor modulators.
93rd CSC Conference, May 29 - June 2, 2010, Toronto. |
13. |
Jha A
Development of Novel Catalytic Inhibitors of Human Topisomerase
2.
12th
International Conference on “The Interface of
Chemistry-Biology in Biomedical Research” February 22-24,
2008, Birla Institute of Technology and Science,
Pilani, Rajasthan, India. [Invited Lecture] |
12. |
Jha A
Novel Inhibitors of Topoisomerase 2. 2nd IUPAC
International Conference
on Green/Sustainable Chemistry, Jan 10-13, 2006, New Delhi, India. [Invited Lecture]. |
11. |
Jha A
Novel Synthesis of 1-Alkyl-2-naphthols. 2nd
International Congress of Chemistry and Environment,
Dec 24-26, 2005, Indore, India. |
10. |
Jha A
2-Tetralone Analogs as Versatile Building Blocks. 88th Conference
of the Canadian Society for Chemistry,
May 28-June 1, 2005, Saskatoon, Canada. |
9. |
Jha A*,
Duffield K
and Mukherjee CM
Design,
Synthesis and Bioevaluation of Novel Anti-neoplastic Agents.
87th
Conference of the Canadian Society for Chemistry,
May 29-June 1, 2004, London, Canada. |
8. |
Jha A Design,
Synthesis and Bioevaluation of Potent Inhibitors of N-myristoyltransferase.
An emerging molecular target for cancer. IUPAC
International Conference on Biodiversity and Natural Products, 26-31
January, 2004, New Delhi, India. [Invited Lecture]. |
7. |
Vaughan
D, Jha A*
Novel molecular frameworks from 2-naphthol analogs.
35th APICS-CIC Conference, Dalhousie University, May 2010. |
6. |
Potter E,
Jha A* Design, Synthesis and Bioevaluation of 3,5-Bisarylmethylene-4-piperidone
Derivatives for Site Specific Delivery. 33rd
APICS-CIC Conference, St Mary's University, May 2008. |
5. |
Huang P-J J,
Mukherjee C, Paul NK, Jha A* Novel Naphthopyrans from
2-Tetralones/2-Naphthols.
32th APICS-CIC Conference, Acadia University, May
2007. [1st Prize,
Organic Chemistry Graduate Category, Atlantic]. |
4. |
McLean E, Mukherjee C, Jha A* Chemoenzymatic Synthesis of Novel Optically
Active
2-Naphthol Mannich bases.
32th APICS-CIC Conference, Acadia University, May
2007. [1st Prize,
Bioorganic Chemistry, Atlantic]. |
3. |
Nichols C,
Youssef D and Jha A*
Synthesis
and Anti-neoplastic Activity of Annulated
1,7-Diarylhepta-1,6-diene-3,5-diones.
31th
APICS-CIC Conference, May 11-13, 2006, Mt. Allison University,
Sackville (NB), Canada. [2nd
Prize, Bioorganic Chemistry, Atlantic]. |
2. |
Nichols C,
Youssef D and Jha A* Synthesis of Novel
Analogs of Curcumin as Potential Anti-neoplastic Agents. 30th
APICS-CIC Conference, May 12-14, 2005, Memorial University of Newfoundland,
St John's (NF), Canada. |
1. |
Beal
J and Jha A* Simple and Facile Synthesis of 12H-Benzo[a]xanthenes
from 2-Tetralone. 30th APICS-CIC Conference, May 12-14, 2005, Memorial University
of Newfoundland, St John's, Canada. |
Conference
Posters Presentations from my Research Group:
42. |
J Melanson,
D Youssef, P JJ Hunag, C Mukherjee, M Deveau, J Richards, A
Jha.*
Environmentally-benign asymmetrization of racemic
substituted 1,3-propanediols.
Atlantic Regional Organic Symposium, Halifax, August 2010. |
41. |
J Melanson,
D Youssef, P JJ Hunag, C Mukherjee, M Deveau, J Richards, A
Jha.*
Environmentally-benign asymmetrization of racemic
substituted 1,3-propanediols.
3rd IUPAC Conference on Green Chemistry, Ottawa, August
2010. |
40. |
J Melanson,
D Youssef, P JJ Hunag, C Mukherjee, M Deveau, J Richards, A
Jha.*
Enzyme-assisted
asymmetrization of racemic substituted 1,3-propanediols.
93rd
CSC Conference,
Toronto, May 2010. |
39. |
J Melanson,
D Youssef, P JJ Hunag, C Mukherjee, M Deveau, J Richards, A
Jha.* Enzyme-assisted
asymmetrization of racemic substituted 1,3-propanediols.
35th APICS-CIC Conference, Dalhousie University, May 2010. |
38. |
A Jha.* Synthetic adventures on
2-tetralones/2-naphthols. 92th
CSC Conference,
Hamilton, May 2009. |
37. |
J Richard,
M Deveau, D Youssef, C Mukherjee, P-JJ Huang, A Jha.*
Enzyme-catalyzed Chemo- and Enantio-selective Acylation of
2,2-Dimethyl-3-aryl-1,3-propanediols.
34rd APICS-CIC Conference, St Francis Xavier
University, May 2009. |
36. |
M Jha,
NK Paul, A Jha.
Antineoplastic 3,5-bis(4-pyridylmethylene)-4-
piperidone derivatives: Novel human topoisomerase 2-alpha
inhibitors.
91th
CSC Conference,
Edmonton, May 2008. |
35. |
E Potter,
D Youssef, E DeClercq, A Jha. Design, synthesis and
bioevaluation of 3,5-bisarylmethylene-4-piperidone
derivatives for site specific delivery. 91th
CSC Conference,
Edmonton, May 2008. |
34. |
P-J J Huang,
A Jha. Novel synthesis of
2,2-dialkyl-3-dialkylamino-2,3-dihydro- 1H-naphtho[2,1-b]pyrans.
33rd APICS-CIC Conference, St Mary's University, May
2008. |
33. |
H Gates,
E Potter, A Jha. Microwave-assisted synthesis of Novel
1,4-bis(arylmethyl)benzene derivatives. 33rd
APICS-CIC Conference, St Mary's University, May 2008. |
32. |
C Mukherjee,
E DeClercq, JP Stables and A Jha*.
Synthesis and topographical studies of 3,5-bis-arylidene-4-piperidone–A
class of potent anticancer agents.
2006 Canadian Society of Pharmaceutical Sciences Symposium,
May 28-June 1, 2007; Montreal (QC). |
31. |
P-J J Huang, C Mukherjee, NK Paul, A Jha*. Novel and convenient
synthesis of 2,3-dihydro-1H-benzo[f]chromenes.
90th
CSC Conference,
Winnipeg, May 2007. |
30. |
E McLean,
C Mukherjee, A Jha*. Enzyme-assisted kinetic resolution of
novel 2-naphthol Mannich bases.
90th
CSC Conference,
Winnipeg, May 2007. |
29. |
M Deveau, D Youssef, C Mukherjee, and A Jha*. Enzyme-assisted enantioselective
acetylation of 2,2-dimethyl-3-aryl-1,3-propanediols.
90th
CSC Conference,
Winnipeg, May 2007. |
28. |
AJ Rolle,
C Mukherjee, E DeClercq, JP Stables and A Jha*. Cytostatic
4’-aminochalcone-based maleimides.
32th APICS-CIC Conference, Acadia University,
May 2007. [1st Prize,
Bioorganic Chemistry, Provincial]. |
27. |
M Deveau, D Youssef, C Mukherjee, and A Jha* “Regio- and enantio-selective
acetylation of 2,2-dimethyl-3-aryl-1,3-propanediols”
32th APICS-CIC Conference, Acadia University, May
2007. [2nd Prize,
Bioorganic Chemistry, Atlantic]. |
26. |
C Mukherjee, E DeClercq, JP Stables and A Jha*.
Synthesis and bioevaluation of 3,5-bis-arylidene-4-piperidone
derivatives as anticancer agents.
2006 Cancer Research Symposium, November 10, 2006; Halifax
(NS), Canada. |
25. |
AJ Rolle, C Mukherjee, E DeClercq, JP Stables and A Jha*.
Cytostatic activity of chalcone-based imides. 2006 Cancer
Research Symposium, November 10, 2006, Halifax (NS), Canada.
[Award Winning Poster,
Provincial] |
24. |
C Nichols, D Youssef, TS Cameron, E DeClercq
and A Jha*. Cytostatic activity of conformationally restrained curcumin
analogs.
2006 Cancer Research Symposium, November 10, 2006; Halifax
(NS), Canada. |
23. |
D Youssef,
E DeClercq
and A Jha*. In-vitro anticancer properties of amino acid conjugates of
3,5-bisarylmethylene-4-piperidone maleamic acids.
2006 Cancer Research Symposium, November 10, 2006; Halifax
(NS), Canada. |
22. |
NK Paul, E DeClercq
and A Jha*. Water-soluble analogs of antineoplastic 3,5-diarylidene-4-piperidone
derivatives.
2006 Cancer Research Symposium, November 10, 2006; Halifax
(NS), Canada. |
21. |
NK Paul, E DeClercq and A
Jha*. Design, Synthesis and Bioevaluation of Water-soluble
Analogues of Antineoplastic 3,5-Diarylidene-4-piperidone
Derivatives.
89th
Conference of the Canadian Society for Chemistry,
May 27-May 31, 2006; Halifax (NS), Canada. |
20. |
D
Youssef, E DeClercq
and A Jha*. Design,
Synthesis and In-vitro Anticancer Properties of Amino
Acid Conjugates of 3,5-Bisarylidene-4-piperidone Maleamic
Acids. 89th
Conference of the Canadian Society for Chemistry,
May 27-May 31, 2006; Halifax (NS), Canada. |
19. |
C Nichols, D
Youssef, TS Cameron, E DeClercq, and A Jha*.
Synthesis
and In-vitro Cytostatic Activity Screening of Cyclic
Curcumin Analogues. 89th
Conference of the Canadian Society for Chemistry,
May 27-May 31, 2006; Halifax (NS), Canada. |
18. |
R Harris,
C Nichols, D Youssef, E DeClercq
and A Jha*. Synthetic
Endeavour towards Heterocyclic Analogs of Curcumin. 31th
APICS-CIC Conference, May 11-13, 2006; Mt. Allison University,
Sackville (NB), Canada. [1nd
Prize, Bioorganic Chemistry, Atlantic]. |
17. |
LM Dietrich,
NK Paul and A Jha*. Synthetic Studies on 2-Naphthol.
31th
APICS-CIC Conference, May 11-13, 2006; Mt. Allison University,
Sackville (NB), Canada. [2006 APICS Communicator Award, Atlantic] |
16. |
R Harris,
C Nichols, D Youssef
and A Jha*. Novel
Analogs of Curcumin as Potential Anti-tumor Agents.
2005 Cancer Research Symposium, November 09, 2005; Halifax
(NS),
Canada. [Norah Stephan Oncology Scholarship Award Poster,
Provincial] |
15. |
A
Jha. Design, Synthesis and Bioevaluation of Potent Inhibitors of
Topoisomerase-II.
88th
Conference of the Canadian Society for Chemistry,
May 28-June 1, 2005; Saskatoon (SK), Canada. |
14. |
S
Trikha,
NK Paul and A Jha* “Unprecedented Conversion of 2-Tetralones to
2-Naphthol Mannich Bases”
88th
Conference of the Canadian Society for Chemistry,
May 28-June 1, 2005; Saskatoon (SK), Canada. |
13. |
D
Youssef
and A Jha*.
Amino
Acid Conjugates of
(3,5-Diarylidene-4-oxo- piperidin-1-yl)-4-oxo-but-2-enoic Acids as
Potential Antineoplastic Agents. 88th
Conference of the Canadian Society for Chemistry,
May 28-June 1, 2005; Saskatoon (SK), Canada. |
12. |
D
Youssef,
C Nichols
and A Jha*.
Novel
Curcumin Analogs as Candidate Anticancer Agents. 88th
Conference of the Canadian Society for Chemistry,
May 28-June 1, 2005; Saskatoon (SK), Canada. |
11. |
MR
Ness
and A Jha*. Synthesis E,E,3,5-Bis(4-carboethoxybenzylidene)-4- oxo-piperidine
Derivatives as Novel Topoisomerase-II Inhibitors.
88th
Conference of the Canadian Society for Chemistry,
May 28-June 1, 2005; Saskatoon (SK), Canada. |
10. |
A Jha. Design, Synthesis and Bioevaluation of Potent Inhibitors of
Topoisomerase-II. CIHR-NSHRF Meeting, May 03, 2005; Halifax (NS), Canada. |
9. |
MR Ness
and A Jha*.
3,5-Bisarylmethylene-4-oxo-piperidine
Derivatives as Novel Topoisomerase-II Inhibitors. 2004 Cancer
Research Symposium, November 04, 2004; Halifax (NS), Canada. |
8. |
MR Ness and A Jha*.
Fine
tuning the anti-neoplastic activity of
3,5-bisarylmethylene-4-oxo-piperidine derivatives.
Pfizer Global R & D Laboratories, October 08, 2004; Groton (CT), USA. [Pfizer SURF Award Poster, International] |
7. |
KM Duffield
and A Jha*.
Fine Tuning the Anticancer Potential of
3,5-Diarylidene-4-oxo-piperidine Derivatives.
87th Conference of
the Canadian Society for Chemistry,
May 29-June 1, 2004; London (ON), Canada. |
6. |
J Zhao,
A Jha*, E DeClercq and TS Cameron.
Cytotoxic
all trans 1-Arylmethylene-3-(3-phenylallylidene)-2-tetralones”
87th Conference of the Canadian Society for Chemistry,
May 29-June 1, 2004; London (ON), Canada. [1st Prize,
Organic Chemistry, National] |
5. |
J Zhao, A Jha*, E DeClercq
and TS Cameron.
Cytotoxic all trans
1-Arylmethylene-3-(3-phenylallylidene)-2-tetralones. 2004 APICS/CIC
Student Chemistry Conference, St. Mary's University, 13-15 May, 2004;
Halifax (NS), Canada.
[2nd
Prize, Organic Chemistry, Atlantic] |
4. |
A Jha,* C Mukherjee, VS Parmar and
AK Prasad. Synthesis and bioevaluation of
4-(3,5bisarylidene-4-oxo-piperidin-1-yl)-4-oxo-N-aryl-but-2E-enamides
as novel anticancer agents. IUPAC International Conference on Biodiversity and Natural Products,
January 26-31, 2004; New Delhi, India. |
3. |
J Zhao and A Jha*.
Design and Synthesis of
1-arylidene-3,4-dihydro-3-(3- arylallylidene)-naphthalen-2(1H)-ones
as
novel anti-neoplastic agents.
2003
Cancer Research Symposium, November 05, 2003; Halifax (NS), Canada. [Award
Winning Poster,
Provincial]. |
2. |
KM Duffield
and A Jha*. Fine
tuning the anticancer potential of
3,5-diarylidene-4-oxo-piperidine derivatives. Pfizer Global
R & D Laboratories, October 10, 2003, Groton (CT), USA. [Pfizer SURF Award 2003 Poster,
International] |
1. |
A Jha*
and C Mukherjee.
Synthesis of
4-(3,5-bisarylidene-4-oxo-piperidin-1-yl)- 4-oxo-but-2-enoic acid arylamides as novel anticancer agents. 39th IUPAC Congress and 86th Conference of the Canadian Society for
Chemistry,
August 14, 2003; Ottawa (ON), Canada. |
|